Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in Combination with Carboplatin in Patients with Advanced Solid Tumors: A Phase I StudyTimothy A. Yap, Simon J. Hollingsworth|Clinical Cancer Research|2021Cited by 134